4//SEC Filing
Regan Barry J. 4
Accession 0001093557-23-000081
CIK 0001093557other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:46 PM ET
Size
8.4 KB
Accession
0001093557-23-000081
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Regan Barry J.
EVP Operations
Transactions
- Disposition to Issuer
Common Stock
2023-03-10$111.40/sh−2,406$268,026→ 75,756 total - Disposition to Issuer
Common Stock
2023-03-10$111.40/sh−3,274$364,720→ 72,482 total - Sale
Common Stock
2023-03-13$106.27/sh−2,010$213,603→ 70,472 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024.
- [F3]On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001746313
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:46 PM ET
- Size
- 8.4 KB